if leronlimab could remedy sepsis for even 10% of patients, would be a moral home run. its like running a suicide hotline - if it saves even one life its worth it. with no side effects, this story keeps getting more and more aggravating by the minute...why the FDA doesnt see it this way is baffling....oh yeah $$$$
would 10% of trial participants survival give a qualifying p-value?
i know nothing about the MOA for sepsis, would love to hear from anyone who does and its obvious role of CCR5
the financial home run is easy too...10% of 270,000 deaths per year = 27,000 x approx $2000 per dose = $54,000,000 / year not too bad